Vault Door

6 Impressive Bank Dividend and Buyback Hikes After Fed-CCAR Results

It was just last week that investors learned that all of the major banks were shown to have passed their Federal Reserve stress tests. Now the capital return plans (CCAR) ...
Read Full Story »
Profit or Loss

Pier 1 Stumbles Over Earnings and Guidance

Pier 1 Imports, Inc. (NYSE: PIR) reported fiscal first-quarter financial results after the markets closed on Wednesday. The company said that it had a net loss of $0.07 per share ...
Read Full Story »
Stock Price

Fitbit, Lipocine Top Wednesday’s 52-Week Low Club

June 29, 2016: Here are four stocks trading with heavy volume among 29 equities making new 52-week lows in Wednesday's session. NYSE advancers led decliners by more than 6 to ...
Read Full Story »
thinkstockphotos-522646895

The 4 Stocks That Boosted the Dow Wednesday

June 29, 2016: Markets opened higher again Wednesday and every sector is again posting a gain as the closing bell approaches. A drawdown in U.S. crude oil inventories coupled with ...
Read Full Story »
clinical trials

Lipocine Crashes After Receiving CRL From the FDA

Lipocine Inc. (NASDAQ: LPCN) is watching its shares get cut in half in Wednesday’s session after receiving a letter from the U.S. Food and Drug Administration (FDA). The company announced ...
Read Full Story »
GE

How SIFI (and TBTF) Designation Removal Will Help GE Ahead

General Electric Co. (NYSE: GE) keeps moving closer and closer to being an industrial conglomerate rather than a conglomerate that is part industrial and part bank. While the company has ...
Read Full Story »
Noodles&Co. store

Noodles & Co. Reveals Data Breach

Fast-casual restaurant chain Noodles & Co. (NASDAQ: NDLS) said Tuesday afternoon that it had uncovered a recent data security incident that may have compromised customer payment information. The customer credit and ...
Read Full Story »
Female patient on gurney

Is Galena Dead in the Water After This Failed Trial?

Galena Biopharma, Inc. (NASDAQ: GALE) is absolutely crashing on Wednesday after the company released further information regarding its Breast Cancer clinical trial. The company announced the recommendation from the Independent ...
Read Full Story »
aluminum cans

Alcoa Offers Details on Split, Investors Head for the Exit

Alcoa Inc. (NYSE: AA) filed a Form 10 initial registration statement with the U.S. Securities and Exchange Commission (SEC) Wednesday morning that gave some details regarding the company's plan to ...
Read Full Story »
Micron chips

Why Analysts Have Such Mixed Emotions on Micron Earnings and Turnaround

Micron Technology, Inc. (NASDAQ: MU) is set to launch the unofficial start of earnings season this week when it reports earnings on Thursday. Technically earnings season will not begin for ...
Read Full Story »
Car Dashboard driving

The Most (and Least) Expensive States to Drive

After housing, transportation is the average American's second largest yearly expense. Gasoline, insurance, and car repairs cost the average driver more than $3,000 annually. A number of factors, such as ...
Read Full Story »
IPO

Talend Files for IPO

Talend S.A. filed a Form F-1 with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering. The company values the offering at up to $86.25 million, although no official ...
Read Full Story »
walmart truck

Walmart Desperately Tries to Take Amazon Customers with Free Shipping

Wal-Mart Stores Inc. (NYSE: WMT) last month dropped the price of its Shipping Pass program by $1 a year, to $49, and improved the basic level of service from 3-day ...
Read Full Story »
Money wallet, income copy

Muted Gains Seen in Personal Income & Spending During May

Wednesday's economic report schedule was a bit on the light side, but there are still plenty of economic and international market events driving the cart. The Bureau of Economic Analysis ...
Read Full Story »
Medicine pills

Eli Lilly Rises on Positive FDA Committee Vote

Eli Lilly and Co. (NYSE: LLY) is watching its shares make a decent gain on Wednesday following a U.S. Food and Drug Administration (FDA) vote. The FDA Advisory Committee voted ...
Read Full Story »